Trial Outcomes & Findings for Intervention to Improve Follow-up of Abnormal Pap Test (NCT NCT00575510)

NCT ID: NCT00575510

Last Updated: 2018-08-23

Results Overview

Attendance at initial appointment to follow-up abnormal Pap test result

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

341 participants

Primary outcome timeframe

adherence rates at initial follow-up appointment, 2 weeks to 3 months

Results posted on

2018-08-23

Participant Flow

Face-to-face recruitment of women 18-55 years of age occurred in 6 University of Texas Medical Branch (UTMB) Regional and Maternal Child Health Program clinics from June 1, 2006-November 30, 2010. Recruitment was interrupted for a period ranging from 2 weeks to 6 months in several clinic sites due to landfall of hurricane Ike on September 13, 2008.

6,179 women were eligible during the recruitment period. Of these, 876 declined participation, 4,671 had a normal Pap test result, 254 did not have a Pap test performed at their clinic visit, and 378 had an abnormal Pap test result and could be randomized. Of these, 90% (341/378)were randomized into the 3-arm trial.

Participant milestones

Participant milestones
Measure
Intervention
Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Active Control
nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Standard Care Only
Clinical standard of care at time of study
Overall Study
STARTED
114
114
113
Overall Study
COMPLETED
102
101
96
Overall Study
NOT COMPLETED
12
13
17

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention
Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Active Control
nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Standard Care Only
Clinical standard of care at time of study
Overall Study
Lost to Follow-up
4
6
9
Overall Study
Withdrawal by Subject
1
0
0
Overall Study
Clinic Called Patient
7
7
7
Overall Study
Pregnancy
0
0
1

Baseline Characteristics

Intervention to Improve Follow-up of Abnormal Pap Test

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention
n=114 Participants
Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Active Control
n=114 Participants
nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Standard Care Only
n=113 Participants
Clinical standard of care at time of study
Total
n=341 Participants
Total of all reporting groups
Age, Continuous
27 years
STANDARD_DEVIATION 7 • n=5 Participants
28 years
STANDARD_DEVIATION 8 • n=7 Participants
29 years
STANDARD_DEVIATION 8 • n=5 Participants
28 years
STANDARD_DEVIATION 7 • n=4 Participants
Sex: Female, Male
Female
114 Participants
n=5 Participants
114 Participants
n=7 Participants
113 Participants
n=5 Participants
341 Participants
n=4 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Region of Enrollment
United States
114 participants
n=5 Participants
114 participants
n=7 Participants
113 participants
n=5 Participants
341 participants
n=4 Participants

PRIMARY outcome

Timeframe: adherence rates at initial follow-up appointment, 2 weeks to 3 months

Attendance at initial appointment to follow-up abnormal Pap test result

Outcome measures

Outcome measures
Measure
Intervention
n=102 Participants
Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling Intervention: Multiple component intervention based in the unified theory of behavior
Active Control
n=101 Participants
nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling Active control: Partial intervention (full intervention minus cultural-specific component)
Standard Care Only
n=96 Participants
Clinical standard of care at time of study
Adherence to Initial Follow-up (Yes/no)
60 percentage of patients who were adherent
54 percentage of patients who were adherent
58 percentage of patients who were adherent

SECONDARY outcome

Timeframe: + 7-30 days post-intervention

Population: Only participants who completed the post-test over the telephone 7-14 following notification of the abnormal Pap test result were asked these questions.

State Anxiety short form measure (6-item); higher scores =worse outcomes (i.e., higher self-reported anxiety levels)

Outcome measures

Outcome measures
Measure
Intervention
n=77 Participants
Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling Intervention: Multiple component intervention based in the unified theory of behavior
Active Control
n=76 Participants
nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling Active control: Partial intervention (full intervention minus cultural-specific component)
Standard Care Only
n=74 Participants
Clinical standard of care at time of study
State Trait Anxiety Inventory (STAI)-State Scale
12 units on a scale
Standard Deviation 5
11 units on a scale
Standard Deviation 4
11 units on a scale
Standard Deviation 4

Adverse Events

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Active Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Care Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Carmen Radecki Breitkopf

Mayo Clinic

Phone: 507-266-0969

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place